Ashfaq Ahmed

Ashfaq Ahmed

Auto-generated profile, based on publicly available information

Ashfaq Ahmed

School of Pharmacy, Brac University, 66 Mohakhali, Dhaka, Bangladesh

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Heliyon
Verified
Journal Article
Open access
AMAbu S. M. Mohsin
Abu S. M. Mohsin
MJMohd Raeed Jamiruddin
Mohd Raeed Jamiruddin
MPMahmudul Kabir Peyal
Mahmudul Kabir Peyal
SSShahana Sharmin
Shahana Sharmin
AAAshfaq Ahmed
Ashfaq Ahmed
DKDr. Eva Rahman Kabir
Dr. Eva Rahman Kabir
In this study, we constructed an UV-C illumination chamber using commercially available germicidal lamps and other locally available low-cost components for general-purpose biological decontamination purposes. The illumination chamber provides uniform illumination of around 1 J/cm2 in under 5 min across the chamber. The control mechanism was developed to automate the on/off process and make it more secure minimizing health and other electrical safety. To validate the decontamination efficacy of the UV-C Illumination Chamber we performed the Geobacillus spore strip culture assay. Additionally, we performed the viral load measurement by identifying the COVID-19-specific N-gene and ORF1 gene on surgical masks. The gold standard RT-qPCR measurement was performed to detect and quantify the COVID-19-specific gene on the mask sample. The biochemical assay was conducted on the control and test group to identify the presence of different types of bacteria, and fungi before and after exposure under the illumination chamber. The findings of our study revealed satisfactory decontamination efficacy test results. Therefore, it could be an excellent device in healthcare settings as a disinfection tool for biological decontamination such as SAR-CoV-2 virus, personal protection equipment (PPE), (including n95, k95 respirators, and surgical masks), and other common pathogens.

23 December 2023 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
AAAshfaq Ahmed
Ashfaq Ahmed
ARA.E. Maisha Rawshan
A.E. Maisha Rawshan
ZTZasia Hossain Tishe
Zasia Hossain Tishe
SSSanjana Shawkat
Sanjana Shawkat
MPMeherun Nessa Popy
Meherun Nessa Popy
MMMd Shaki Mostaid
Md Shaki Mostaid

20 May 2026 in Journal of Current Health Sciences
Verified
Journal Article
Open access
AAAshfaq Ahmed
Ashfaq Ahmed
HIHrishik Iqbal
Hrishik Iqbal
MMMd Shaki Mostaid
Md Shaki Mostaid
AZAfroza Zannat
Afroza Zannat
SCSrikumar Chakravarthi
Srikumar Chakravarthi
NSNikolaos Syrmos
Nikolaos Syrmos
The COVID-19 pandemic, caused by SARS-CoV-2, has emerged as a global health crisis, with severe disease and mortality disproportionately affecting individuals with comorbidities such as cardiovascular disease, diabetes, obesity, and immunosuppression. These conditions are associated with elevated basal reactive oxygen species (ROS) levels, predisposing patients to oxidative stress, systemic inflammation, endothelial dysfunction, and thrombotic complications. SARS-CoV-2 infection further exacerbates ROS generation via dysregulation of the renin–angiotensin system, NADPH oxidase activation, and immune-mediated neutrophil and macrophage responses, contributing to vascular injury, cytokine storm, and acute respiratory distress syndrome (ARDS). Hypercholesterolemic patients are particularly vulnerable, as oxidized LDL (OxLDL) enhances ROS production, promotes neutrophil extracellular trap formation, and accelerates thrombosis, further compounding COVID-19 severity. COVID-19–associated coagulopathy is characterized by elevated D-dimer, von Willebrand factor, and platelet activation, reflecting systemic hypercoagulability and multiorgan involvement. Therapeutically, targeting oxidative stress represents a promising strategy. Statins exhibit cholesterol-lowering and immunomodulatory effects, potentially reducing thrombotic risk. Nrf2 activators, glutathione, and N-acetylcysteine enhance endogenous antioxidant defenses, mitigate inflammation, and preserve endothelial integrity. Micronutrients such as vitamins C, D, E, and selenium further support redox homeostasis and immune function. Collectively, in this narrative review we have shown that understanding the interplay between oxidative stress, thrombosis, hypercholesterolemia, and immune dysregulation may inform preventive and therapeutic strategies to improve outcomes in high-risk COVID-19 patients. Clinical trials are warranted to validate the efficacy of these interventions.